10-QPeriod: Q2 FY2006

ENTEGRIS INC Quarterly Report for Q2 Ended Apr 1, 2006

Filed May 11, 2006For Securities:ENTG

Summary

Entegris, Inc. (ENTG) reported strong top-line growth in the three months ended April 1, 2006, with net sales increasing 84% year-over-year to $157.7 million. This significant growth was primarily driven by the inclusion of sales from the Mykrolis merger, which expanded the company's product portfolio in materials integrity management for the semiconductor industry. While gross profit and margins improved due to higher sales and the contribution of higher-margin products from Mykrolis, operating expenses also saw a substantial increase, largely due to integration costs associated with the merger. Net income rose to $11.4 million ($0.08 per diluted share) from $7.1 million ($0.09 per diluted share) in the prior year period. The company continued its strategic divestiture of non-core product lines, classifying them as discontinued operations. Entegris appears well-positioned for the coming year, with sufficient liquidity and a clear strategy for integrating the Mykrolis acquisition and realizing cost synergies.

Key Highlights

  • 1Net sales surged by 84% year-over-year to $157.7 million, largely due to the Mykrolis merger adding significant revenue streams.
  • 2Gross profit increased by 101% to $73.0 million, with gross margin improving to 46.3% from 42.4%, benefiting from increased sales volume and higher-margin products.
  • 3Operating expenses, particularly SG&A, rose significantly due to Mykrolis integration costs, increasing by 118% to $52.1 million.
  • 4Net income grew to $11.4 million ($0.08 EPS) from $7.1 million ($0.09 EPS) in the prior year period, with continuing operations contributing $9.8 million.
  • 5The company generated $1.1 million in cash from operating activities, though this was offset by increases in receivables and inventory.
  • 6Short-term investments and cash and cash equivalents totaled $283.2 million at the end of the quarter, indicating strong liquidity.
  • 7Divestiture of gas delivery, life science, and tape and reel product lines are classified as discontinued operations, impacting comparability but signaling a focused strategy.

Frequently Asked Questions

The primary driver for the 84% year-over-year increase in net sales to $157.7 million was the inclusion of sales from the recently completed merger with Mykrolis Corporation, which significantly expanded Entegris' product offerings and market reach.

The merger led to a substantial increase in operating expenses, particularly in Selling, General, and Administrative (SG&A) costs, which rose by 118% to $52.1 million. This increase was attributed to the integration of Mykrolis' infrastructure, increased amortization of intangibles, and specific costs associated with integrating the two companies' operations.

Entegris reported strong liquidity with $283.2 million in cash, cash equivalents, and short-term investments as of April 1, 2006. The company anticipates that its current cash flow, existing investments, and available credit facilities will be sufficient to meet its working capital and investment needs for the next 12 months.

The company is divesting its gas delivery, life science, and tape and reel product lines. The life science and tape and reel product lines were sold in December 2005, and the gas delivery product line was sold in February 2006. The financial results of these divested businesses are now reported as discontinued operations.